Strategies for Treatment of Thyroid Cancer

被引:4
作者
Yadav, Deepika [1 ]
Sharma, Pramod Kumar [1 ]
Malviya, Rishabha [1 ]
Mishra, Prem Shankar [1 ]
机构
[1] Galgotias Univ, Sch Med & Allied Sci, Dept Pharm, Greater Noida, Uttar Pradesh, India
关键词
Thyroid cancer; radioactive iodine; molecular therapy; ablation treatment; thyroidectomy; novel target therapy; RET/PTC ONCOGENE ACTIVATION; PHASE-II TRIAL; RET PROTOONCOGENE; PAPILLARY CARCINOMAS; CURRENT DIAGNOSIS; KINASE INHIBITOR; HIGH-FREQUENCY; RAS; REARRANGEMENTS; TUMORS;
D O I
10.2174/1389450124666230222093308
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
More people are diagnosed with thyroid cancer than any other endocrine tumor. Differentiated thyroid cancer is often treated by removing the thyroid gland (thyroidectomy), iodizing radiation, or inhibiting thyroid stimulating hormone (TSH). Advanced thyroid carcinomas are notoriously resistant to chemotherapy, thus the pursuit of alternative treatments is vital. The best methods for treating individuals with advanced nonmedullary and medullary thyroid carcinomas are discussed in this post. Numerous tyrosine kinase inhibitors and antiangiogenic inhibitors, two types of novel target therapy, have shown promise in studies for individuals with thyroid cancer. Both the positive and unfavourable outcomes of clinical studies of these drugs were addressed. The findings presented here are encouraging, but more study is required to establish whether or not this method is effective in the treatment of thyroid cancer.
引用
收藏
页码:406 / 415
页数:10
相关论文
共 50 条
  • [21] New treatment modalities in advanced thyroid cancer
    Kapiteijn, E.
    Schneider, T. C.
    Morreau, H.
    Gelderblom, H.
    Nortier, J. W. R.
    Smit, J. W. A.
    ANNALS OF ONCOLOGY, 2012, 23 (01) : 10 - 18
  • [22] The discovery and development of sorafenib for the treatment of thyroid cancer
    White, Peter T.
    Cohen, Mark S.
    EXPERT OPINION ON DRUG DISCOVERY, 2015, 10 (04) : 427 - 439
  • [23] Sorafenib for the treatment of thyroid cancer: an updated review
    Krajewska, Jolanta
    Handkiewicz-Junak, Daria
    Jarzab, Barbara
    EXPERT OPINION ON PHARMACOTHERAPY, 2015, 16 (04) : 573 - 583
  • [24] SEOM clinical guidelines for the treatment of thyroid cancer
    Martinez Trufero, Javier
    Capdevilla, Jaume
    Jesus Cruz, Juan
    Isla, Dolores
    CLINICAL & TRANSLATIONAL ONCOLOGY, 2011, 13 (08) : 574 - 579
  • [25] The Prognostic Implications from Molecular Testing of Thyroid Cancer
    Ozgursoy, Ozan B.
    Eisele, David W.
    Tufano, Ralph P.
    OTOLARYNGOLOGIC CLINICS OF NORTH AMERICA, 2014, 47 (04) : 595 - +
  • [26] Combination Strategies Involving Immune Checkpoint Inhibitors and Tyrosine Kinase or BRAF Inhibitors in Aggressive Thyroid Cancer
    Ragusa, Francesca
    Ferrari, Silvia Martina
    Elia, Giusy
    Paparo, Sabrina Rosaria
    Balestri, Eugenia
    Botrini, Chiara
    Patrizio, Armando
    Mazzi, Valeria
    Guglielmi, Giovanni
    Foddis, Rudy
    Spinelli, Claudio
    Ulisse, Salvatore
    Antonelli, Alessandro
    Fallahi, Poupak
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2022, 23 (10)
  • [27] Neck Dissection in the Surgical Treatment of Thyroid Cancer
    Eltelety, Ahmad M.
    Terris, David J.
    ENDOCRINOLOGY AND METABOLISM CLINICS OF NORTH AMERICA, 2019, 48 (01) : 143 - +
  • [28] Thyroid Follicular Epithelial Cell-Derived Cancer: New Approaches and Treatment Strategies
    Bolin, Julie
    JOURNAL OF NUCLEAR MEDICINE TECHNOLOGY, 2021, 49 (03) : 199 - 208
  • [29] Molecular basis and targeted therapy in thyroid cancer: Progress and opportunities
    Zhang, Lizhuo
    Feng, Qingqing
    Wang, Jiafeng
    Tan, Zhuo
    Li, Qinglin
    Ge, Minghua
    BIOCHIMICA ET BIOPHYSICA ACTA-REVIEWS ON CANCER, 2023, 1878 (04):
  • [30] Current treatment strategies for papillary thyroid microcarcinoma
    Weber, Theresia
    AUSTRIAN JOURNAL OF CLINICAL ENDOCRINOLOGY AND METABOLISM, 2021, 14 (04): : 140 - 144